ZHE DA DIXUN

Serial Number 97538530
Registration 7645016
700

Registration Progress

Application Filed
Aug 6, 2022
Under Examination
Oct 31, 2023
Approved for Publication
Sep 5, 2023
Published for Opposition
Sep 5, 2023
Registered
Jan 7, 2025

Trademark Image

ZHE DA DIXUN

Basic Information

Serial Number
97538530
Registration Number
7645016
Filing Date
August 6, 2022
Registration Date
January 7, 2025
Published for Opposition
September 5, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2025
Registration
Registered
Classes
044

Rights Holder

Hangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd

99
Address
Rm. 201, Bldg. 2, No. 568,
Binkang Rd., Binjiang Dist.,
Hangzhou, Zhejiang 310052
CN

Ownership History

Hangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd

Original Applicant
99
Hangzhou, Zhejiang CN

Hangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd

Owner at Publication
99
Hangzhou, Zhejiang CN

Hangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd

Original Registrant
99
Hangzhou, Zhejiang CN

Legal Representation

Attorney
Kevin O'Keefe

USPTO Deadlines

Next Deadline
2005 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

46 events
Date Code Type Description
Jan 7, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 13, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 13, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 1, 2024 DOCK D ASSIGNED TO EXAMINER
Nov 18, 2024 ALIE A ASSIGNED TO LIE
Nov 18, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2024 GNRT O NON-FINAL ACTION E-MAILED
Jun 10, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN
May 3, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
May 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 30, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 11, 2024 IUAF S USE AMENDMENT FILED
Apr 11, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 11, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 11, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 11, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 31, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 PUBO A PUBLISHED FOR OPPOSITION
Aug 16, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 3, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 3, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
Aug 3, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jul 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2023 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jul 25, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2023 GNRT F NON-FINAL ACTION E-MAILED
May 26, 2023 CNRT R NON-FINAL ACTION WRITTEN
May 24, 2023 DOCK D ASSIGNED TO EXAMINER
Aug 30, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Health assessment services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical clinic services; Medical equipment rental; Medical screening; Medical services in the nature of administering vaccines; Medical treatment using cultured cells; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services
First Use Anywhere: Nov 14, 2022
First Use in Commerce: Nov 20, 2022

Additional Information

Design Mark
The mark consists of a drawing of a gene strand pattern surrounded by a small circle, four Chinese characters above the pattern, and the stylized English wording "ZHE DA DIXUN" below it, all of which is surrounded by a larger circle.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of the Chinese characters for "Zhe", "Da", "Di" and "Xun" in the mark is "Zhejiang", "Big", "Direct" and "Fast", respectively. However, the combination of wording has no meaning in English; The wording ZHE DA DIXUN has no meaning in a foreign language.
Other
The non-Latin characters in the mark transliterate to "ZHE DA DI XUN" and this means "Zhejiang, Big, Direct, Fast" in English.

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
the non-Latin characters that transliterate to "ZHEJIANG"